|
| 16/10/2000 |
ALIZYME PROPOSED ADMISSION TO OFFICIAL LIST, TO TRADING ON THE LONDON STOCK EXCHANGE AND INCLUSION IN techMARK |
|
| 16/10/2000 |
ALIZYME GRANTED APPROVAL TO COMMENCE PHASE Ib CLINICAL TRIAL FOR OBESITY DRUG ATL-962 |
|
| 16/10/2000 |
ALIZYME SUCCESSFULLY COMPLETES PHASE IIa CLINICAL TRIAL OF ATL-1251 IN IBS |
|
| 21/09/2000 |
INTERIM REPORT FOR THE SIX MONTHS ENDED 30 JUNE 2000 |
|
| 07/07/2000 |
SUCCESSFUL COMPLETION OF PHASE Ia CLINICAL TRIAL FOR OBESITY DRUG ATL-962 |
|
| 09/05/2000 |
ANNUAL GENERAL MEETING AND OVERVIEW |
|
| 05/04/2000 |
ALIZYME COMPLETES PRECLINICAL DEVELOPMENT OF OBESITY DRUG ATL-962 |
|
| 06/03/2000 |
ALIZYME GRANTED LICENSE TO MANUFACTURING TECHNOLOGY AND RECEIVES NOTICE OF ALLOWANCE OF U.S. PATENT FOR ITS MUCOSITIS PRODUCT, ATL-101. |
|
| 27/01/2000 |
ALIZYME plc PRELIMINARY RESULTS FOR THE YEAR ENDED 31 DECEMBER 1999 |
|
| 21/01/2000 |
ALIZYME plc PRELIMINARY RESULTS NOTIFICATION |
|
Help